Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Effectiveness, Safety, and Economic Comparison of Inhaled Epoprostenol Brands, Flolan and Veletri, in Acute Respiratory Distress Syndrome.

Hawn JM, Bauer SR, Wanek MR, Li M, Wang X, Duggal A, Torbic H.

Ann Pharmacother. 2019 Nov 15:1060028019888853. doi: 10.1177/1060028019888853. [Epub ahead of print]

PMID:
31729256
2.

Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.

Yerke JR, Sacha GL, Scheraga RG, Culver DA, Abraham S, Torbic H, Lam SW, Ammar MA, Olman MA, Bauer SR.

Pharmacotherapy. 2019 Nov 9. doi: 10.1002/phar.2346. [Epub ahead of print]

PMID:
31705703
3.

Combined Immunodeficiency With Inflammatory Bowel Disease in a Patient With TTC7A Deficiency.

Broome DT, Young A, Torbic H, Krishnan S, Gordon I, Lai K, Rizk M, Rieder F.

ACG Case Rep J. 2019 Apr 25;6(5):e00061. doi: 10.14309/crj.0000000000000061. eCollection 2019 May.

4.

Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension.

Narechania S, Torbic H, Tonelli AR.

J Cardiovasc Pharmacol Ther. 2019 Oct 8:1074248419877409. doi: 10.1177/1074248419877409. [Epub ahead of print]

PMID:
31594400
5.

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?

Torbic H, Krishnan S, Duggal A.

Crit Care. 2019 Sep 6;23(1):305. doi: 10.1186/s13054-019-2586-3. No abstract available.

6.

Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade.

Bass S, Vance ML, Reddy A, Bauer SR, Roach E, Torbic H, Welch S, Duggal A.

Am J Crit Care. 2019 Sep;28(5):377-384. doi: 10.4037/ajcc2019917.

PMID:
31474608
7.

Correction to: Clinical predictors of renal non-recovery in acute respiratory distress syndrome.

Panitchote A, Mehkri O, Hastings A, Hanane T, Demirjian S, Torbic H, Mireles-Cabodevila E, Krishnan S, Duggal A.

BMC Nephrol. 2019 Jul 30;20(1):286. doi: 10.1186/s12882-019-1479-7.

8.

Correction to: Factors associated with acute kidney injury in acute respiratory distress syndrome.

Panitchote A, Mehkri O, Hastings A, Hanane T, Demirjian S, Torbic H, Mireles-Cabodevila E, Krishnan S, Duggal A.

Ann Intensive Care. 2019 Jul 23;9(1):84. doi: 10.1186/s13613-019-0558-z.

9.

Clinical predictors of renal non-recovery in acute respiratory distress syndrome.

Panitchote A, Mehkri O, Hastings A, Hanane T, Demirjian S, Torbic H, Mireles-Cabodevila E, Krishnan S, Duggal A.

BMC Nephrol. 2019 Jul 10;20(1):255. doi: 10.1186/s12882-019-1439-2. Erratum in: BMC Nephrol. 2019 Jul 30;20(1):286.

10.

Factors associated with acute kidney injury in acute respiratory distress syndrome.

Panitchote A, Mehkri O, Hastings A, Hanane T, Demirjian S, Torbic H, Mireles-Cabodevila E, Krishnan S, Duggal A.

Ann Intensive Care. 2019 Jul 1;9(1):74. doi: 10.1186/s13613-019-0552-5. Erratum in: Ann Intensive Care. 2019 Jul 23;9(1):84.

11.

Effectiveness of venous thromboembolism prophylaxis in patients with liver disease.

Yerke J, Bauer SR, Bass S, Torbic H, Militello M, Roach E, Hanouneh I, Welch S.

World J Hepatol. 2019 Apr 27;11(4):379-390. doi: 10.4254/wjh.v11.i4.379.

12.

Management of Pulmonary Arterial Hypertension in the ICU.

Torbic H.

J Pharm Pract. 2019 Jun;32(3):303-313. doi: 10.1177/0897190019838110. Epub 2019 Mar 25.

PMID:
30909801
13.

Neuromuscular blocking agents for acute respiratory distress syndrome.

Torbic H, Duggal A.

J Crit Care. 2019 Feb;49:179-184. doi: 10.1016/j.jcrc.2018.10.019. Epub 2018 Oct 28. Review.

PMID:
30396789
14.

Prophylactic Haloperidol for Critically Ill Adults.

Torbic H, Duggal A.

JAMA. 2018 Jul 17;320(3):303-304. doi: 10.1001/jama.2018.6045. No abstract available.

PMID:
30027243
15.

Effectiveness, safety, and Economic Comparison of Two Inhaled Epoprostentol Products (Flolan and Veletri) in Cardiothoracic Surgery Patients.

Hawn JM, Wanek M, Bauer SR, Ammar MA, Insler S, Adi A, Torbic H.

Ann Pharmacother. 2018 Oct;52(10):956-964. doi: 10.1177/1060028018776432. Epub 2018 May 11.

PMID:
29749260
16.

Predictors of response to fixed-dose vasopressin in adult patients with septic shock.

Sacha GL, Lam SW, Duggal A, Torbic H, Bass SN, Welch SC, Butler RS, Bauer SR.

Ann Intensive Care. 2018 Mar 6;8(1):35. doi: 10.1186/s13613-018-0379-5.

17.

Antipsychotics, Delirium, and Acute Respiratory Distress Syndrome: What Is the Link?

Torbic H, Duggal A.

Pharmacotherapy. 2018 Apr;38(4):462-469. doi: 10.1002/phar.2093. Epub 2018 Mar 22. Review.

PMID:
29444340
18.

Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.

Sacha GL, Lam SW, Duggal A, Torbic H, Reddy AJ, Bauer SR.

Pharmacotherapy. 2018 Mar;38(3):319-326. doi: 10.1002/phar.2082. Epub 2018 Feb 8.

PMID:
29328496
19.

Body Mass's Impact on Response to Fixed-Dose Vasopressin in Patients With Septic Shock.

Torbic H, Sacha GL, Bauer SR, Lam SW.

Shock. 2018 Oct;50(4):388-394. doi: 10.1097/SHK.0000000000001086.

PMID:
29240642
20.

Safe administration of intrapleural alteplase during pregnancy.

Torbic H, Inaty H, Raja S, Choi H.

J Thorac Dis. 2017 Sep;9(9):E801-E804. doi: 10.21037/jtd.2017.07.114.

Supplemental Content

Loading ...
Support Center